For the quarter ending 2026-03-31, CYN had $22,938,748 increase in cash & cash equivalents over the period. $9,014,813 in free cash flow.
| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|
| Realized gain on short-term investments | - | 228,770 | 316,324 | 113,072 |
| Patent impairment | - | - | 0 | 118,831 |
| Warrant liability issuance costs | - | - | - | -1,739,148 |
| Loss on disposed assets | - | -1,003 | -10,426 | - |
| Change in fair value of warrant liability | - | -3,681,195 | 2,544,518 | 5,359,780 |
| Net loss | 11,311,841 | -4,757,446 | -13,041,154 | -33,335,579 |
| Depreciation and amortization | -577,707 | 291,196 | 603,116 | 669,409 |
| Stock-based compensation | -961,698 | 354,856 | 993,131 | 2,449,191 |
| Accretion on short-term investments | 432,942 | - | - | - |
| Loss on issuance of warrants | - | - | - | -2,344,147 |
| Accounts and other receivables | 1,187,681 | - | - | - |
| Accretion of interest and amortization of debt issuance costs | - | - | - | 1,177,174 |
| Change in estimate of capitalized software | - | 2,590,491 | - | - |
| Inventory | -255,340 | - | - | - |
| Prepaid expenses, operating lease right-of-use assets, and other assets | -2,415,068 | -194,380 | 2,953,162 | 646,282 |
| Accounts payable | 42,637 | 184,147 | -71,509 | 50,815 |
| Deferred revenue | 591,940 | - | - | - |
| Accrued expenses, lease liabilities, and other current liabilities | -2,104,716 | 986,159 | -539,405 | 990,357 |
| Net cash used in operating activities | 8,431,933 | -4,065,179 | -12,770,363 | -19,196,081 |
| Purchase of property and equipment | -582,880 | 519,516 | 352,853 | 1,051,481 |
| Acquisition of intangible asset | -1,185,681 | 3,954 | 1,186,659 | 954,229 |
| Disposal of assets | - | - | - | 265,940 |
| Purchase of short-term investments | -41,732,161 | 31,905,100 | 30,805,799 | 7,562,761 |
| Proceeds from maturity of short-term investments | -17,299,148 | 9,971,000 | 23,230,501 | 12,237,761 |
| Net cash used in investing activities | 26,201,574 | -22,457,570 | -9,114,810 | 2,935,230 |
| Proceeds from public issuance of common stock and pre-funded warrants, net of issuance costs | - | 0 | 29,611,678 | 18,260,852 |
| Issuance costs for stock dividend and restricted stock units | - | - | 0 | - |
| Proceeds from the notes, net of issuance costs | - | - | - | 1,801,265 |
| Issuance costs from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants | - | 0 | 1,025 | 13,811,014 |
| Repayment of the notes | - | - | - | 4,375,000 |
| Proceeds from at-the-market equity financing, net of issuance costs | 9,166,427 | - | 0 | 6,789,427 |
| Issuance costs for stock dividend and restricted stock units | - | - | - | 597 |
| Proceeds from public issuance of common stock, net of offering costs | 8,749,467 | - | - | - |
| Net cash provided by (used in) financing activities | -11,694,759 | 0 | 29,610,653 | 36,286,961 |
| Net increase (decrease) in cash and cash equivalents | 22,938,748 | -26,522,749 | 7,725,480 | 20,026,110 |
| Cash and cash equivalents at beginning of period | 4,820,464 | 23,617,733 | - | 3,591,623 |
| Cash and cash equivalents at end of period | 5,131,502 | 4,820,464 | - | 23,617,733 |
Cyngn Inc. (CYN)
Cyngn Inc. (CYN)